{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:34Z","timestamp":1760854114540},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2&3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Pain management is a challenging and unmet medical need. Despite their demonstrated efficacy, currently used opioid drugs and nonsteroidal anti-inflammatory drugs are frequently associated with several adverse events. The identification of new and safe analgesics is therefore needed. MP1104, an analogue of 3\u2032\u2212iodobenzoyl naltrexamine, is a potent nonselective full agonist at mu (MOR), kappa (KOR), and delta (DOR) opioid receptors, respectively. It was shown to possess potent antinociceptive effects in acute thermal pain assays without aversion in mice. In this study, we investigated MP1104 in the formalin test, a model of tonic pain. MP1104 (0.05, 0.1, and 1.0\u2009mg\/kg) reduced pain-like behaviors in phases I and II of the formalin test in male and female ICR mice. Pretreatment with KOR antagonist (norbinaltorphimine 10\u2009mg\/kg) and DOR antagonist (naltrindole 10\u2009mg\/kg) abolished the antinociceptive effects of MP1104 in the formalin test. These findings support the development of MP1104 for further testing in other pain models.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000541","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T16:28:45Z","timestamp":1584116925000},"page":"174-178","source":"Crossref","is-referenced-by-count":12,"title":["The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test"],"prefix":"10.1097","volume":"31","author":[{"given":"Esad","family":"Ulker","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisam","family":"Toma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"White","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Uprety","sequence":"additional","affiliation":[{"name":"bDepartment of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susruta","family":"Majumdar","sequence":"additional","affiliation":[{"name":"cCenter for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Imad","family":"Damaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3959(94)00095-V","article-title":"The formalin test: scoring properties of the first and second phases of the pain response in rats.","volume":"60","author":"Abbott","year":"1995","journal-title":"Pain"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2019.02.010","article-title":"MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.","volume":"150","author":"Atigari","year":"2019","journal-title":"Neuropharmacology"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2015.11.024","article-title":"Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.","volume":"102","author":"Bagdas","year":"2016","journal-title":"Neuropharmacology"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","article-title":"Structure of the nanobody-stabilized active state of the kappa opioid receptor.","volume":"172","author":"Che","year":"2018","journal-title":"Cell"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1038\/s41467-019-11158-0","article-title":"Long-term imaging of dorsal root ganglia in awake behaving mice.","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/bjaceaccp\/mku044","article-title":"Transition from acute to chronic pain.","volume":"15","author":"Feizerfan","year":"2015","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"R7-20230910","first-page":"1748","article-title":"Naloxone blocks the beneficial effects of aqueous extract of Murraya koenigii (L.) Spreng leaves in models of pain.","volume":"17","author":"Gupta","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1744-8069-10-62","article-title":"Sustained pain-related depression of behavior: effects of intraplantar formalin and complete Freund\u2019s adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.","volume":"10","author":"Leitl","year":"2014","journal-title":"Mol Pain"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain.","volume":"39","author":"Liu","year":"2019","journal-title":"J Neurosci"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13776","article-title":"Increases in drug and opioid overdose deaths-United States, 2000-2014.","volume":"16","author":"Rudd","year":"2016","journal-title":"Am J Transplant"},{"key":"R11-20230910","first-page":"971","article-title":"Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.","volume":"247","author":"Takemori","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bph.12810","article-title":"Anti-nociception mediated by a \u03ba opioid receptor agonist is blocked by a \u03b4 receptor agonist.","volume":"172","author":"Taylor","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method.","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/acschemneuro.5b00153","article-title":"Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.","volume":"6","author":"V\u00e1radi","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3959(96)03299-X","article-title":"Optimal scoring strategies and weights for the formalin test in rats.","volume":"70","author":"Watson","year":"1997","journal-title":"Pain"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:17:44Z","timestamp":1694333864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":15,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000541","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}